Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Dahlia Garza"'
Autor:
Rajiv Agarwal, Patrick Rossignol, Bryan Williams, Alain Romero, Martha Mayo, William B. White, Jia Ma, Suzette Warren, Dahlia Garza
Publikováno v:
The Lancet. 394:1540-1550
Summary Background Spironolactone is effective at reducing blood pressure in patients with uncontrolled resistant hypertension. However, the use of spironolactone in patients with chronic kidney disease can be restricted by hyperkalaemia. We evaluate
Autor:
Lance Berman, Martha Mayo, Bertram Pitt, Mitja Lainscak, George L. Bakris, Matthew R. Weir, Rezi Zawadzki, Mason W. Freeman, David A. Bushinsky, Dahlia Garza
Publikováno v:
ESC Heart Failure. 5:592-602
Aims Chronic kidney disease (CKD) in heart failure (HF) increases the risk of hyperkalaemia (HK), limiting angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) use. Patiromer is a sodium-free, non-absorbed potassium b
Autor:
Lance Berman, Frank Ruschitzka, Marco Metra, Dahlia Garza, Dalane W. Kitzman, Charles Du Mond, Bertram Pitt, Gerasimos Filippatos, Patiromer Investigators, Patrick Rossignol, Mitja Lainscak, David A. Bushinsky
Publikováno v:
ESC Heart Failure. 5:257-266
AIMS Hyperkalaemia risk precludes optimal renin-angiotensin-aldosterone system inhibitor use in patients with heart failure (HF), particularly those with chronic kidney disease (CKD). Patiromer is a sodium-free, non-absorbed potassium (K)-binding pol
Autor:
Bryan Williams, Rajiv Agarwal, Alain Romero, Martha Mayo, Dahlia Garza, Suzette Warren, Susan Arthur, Patrick Rossignol, William B. White
Publikováno v:
American Journal of Nephrology. 48:172-180
Background: While chronic kidney disease (CKD) is common in resistant hypertension (RHTN), prior studies evaluating mineralocorticoid receptor antagonists excluded patients with reduced kidney function due to risk of hyperkalemia. AMBER (ClinicalTr
Autor:
Martha Mayo, Susan Arthur, Murray Epstein, Matthew R. Weir, Lance Berman, Dahlia Garza, David A. Bushinsky, Daniel J. Wilson
Publikováno v:
Journal of Hypertension
Objective: Recurrent hyperkalemia frequently limits use of renin–angiotensin–aldosterone system inhibitors (RAASi) in chronic kidney disease (CKD) patients with hypertension, diabetes, and/or heart failure. Patiromer is a sodium-free, nonabsorbed
Autor:
Alan Charney, Rajiv Agarwal, Bhupinder Singh, Dahlia Garza, David G. Warnock, Jonathan H. Seltzer, William C. Cushman, Salim Shah, Michael Walsh, Bengt Fellström, Peter G. M. Mol, Bernard Canaud, Nicolas Guzman, Janet Wittes, Faiez Zannad, Christopher S. Wilcox, Jonathan C. Craig, Bergur V. Stefánsson, Frank A. Holtkamp, Amil M. Shah, Gérard M. London, Luis M. Ruilope, Yves Rosenberg, Ron T. Gansevoort, Christoph Wanner, Ziad A. Massy, Gilles Chatellier, Aliza Thompson, Alexandre Mebazaa, Wendy Gattis Stough, Bertram Pitt, Kristian Thygesen, Marc A. Pfeffer, Norman Stockbridge, Patrick Rossignol
Publikováno v:
European Heart Journal, 40(11), 880-887. Oxford University Press
Rossignol, P, Agarwal, R, Canaud, B, Charney, A, Chatellier, G, Craig, J C, Cushman, W C, Gansevoort, R T, Fellström, B, Garza, D, Guzman, N, Holtkamp, F A, London, G M, Massy, Z A, Mebazaa, A, Mol, P G M, Pfeffer, M A, Rosenberg, Y, Ruilope, L M, Seltzer, J, Shah, A M, Shah, S, Singh, B, Stefánsson, B V, Stockbridge, N, Stough, W G, Thygesen, K, Walsh, M, Wanner, C, Warnock, D G, Wilcox, C S, Wittes, J, Pitt, B, Thompson, A & Zannad, F 2019, ' Cardiovascular outcome trials in patients with chronic kidney disease : Challenges associated with selection of patients and endpoints ', European Heart Journal, vol. 40, no. 11, pp. 880-886 . https://doi.org/10.1093/eurheartj/ehx209
Rossignol, P, Agarwal, R, Canaud, B, Charney, A, Chatellier, G, Craig, J C, Cushman, W C, Gansevoort, R T, Fellström, B, Garza, D, Guzman, N, Holtkamp, F A, London, G M, Massy, Z A, Mebazaa, A, Mol, P G M, Pfeffer, M A, Rosenberg, Y, Ruilope, L M, Seltzer, J, Shah, A M, Shah, S, Singh, B, Stefánsson, B V, Stockbridge, N, Stough, W G, Thygesen, K, Walsh, M, Wanner, C, Warnock, D G, Wilcox, C S, Wittes, J, Pitt, B, Thompson, A & Zannad, F 2019, ' Cardiovascular outcome trials in patients with chronic kidney disease : Challenges associated with selection of patients and endpoints ', European Heart Journal, vol. 40, no. 11, pp. 880-886 . https://doi.org/10.1093/eurheartj/ehx209
Although cardiovascular disease is a major health burden for patients with chronic kidney disease, most cardiovascular outcome trials have excluded patients with advanced chronic kidney disease. Moreover, the major cardiovascular outcome trials that
Autor:
Mary, Bridgeman, Donna, Prete, Nicole, Rolston, Daniel, Abazia, Marc, Sturgill, Laura, Finn, Deborah, Summers, Marketa, Marvanova, Paul, Henkel, Jayson, Thompson, Mark, Dewey, Daniel, Friesner, Carolyn, Alessi, Lourdes, Cuellar, Lisa, Yamagishi, Christine, O'Neil, Olivia, Erickson, Kelly, Mazzei, Khalid, Kamal, Nicole, Early, Brian, Bainter, Laura, Hanson, Emily, Schmitz, Amanda, Loomis, Marissa, Norberto, Anne, Hume, Marsha, Meyer, Romilla, Batra, Denise, Likar, Susan, Enguidanos, Catherine, Liu, Brian, Kotansky, Ann, Fisher, Christine M, Ruby, Jennifer, Pruskowski, Siti Nurhana Abdul, Karim, Belinda Soon Wei, Yong, Patricia, Slattum, Ericka, Crouse, Jeffrey, Delafuente, Krista, Donohoe, Kelechi, Ogbonna, Emily, Peron, Kacie, Powers, Elvin, Price, Kristin, Zimmerman, Sarah, Rahim, Tracey, Gendron, Clarissa, Cho, Lindsay, Elliott, Candace, Minter, Mary, Morin, Leisa, Marshall, Gregg, Stevens, Charles, Cordaro, Matthew, Hill, Kayla, Nagy, Kelly Reilly, Kroustos, Kristen Finley, Sobota, Rebecca, Mahan, Trista, Bailey, Kara, Ioannou, Diana, Mansour, Tristan, Thompson, Kristel, Chatellier, Amanda, Schwenk, Christine, Ruby, Tsuhua Susan, Chen, Shilun, Li, Marian, James, Maria, Spilios, Andrea, Leschak, Alexander, Levine, Stephanie, Forgette, Nneka, Oluigbo, Doreen, Szollosi, Dzifa, Avalime, Salome Bwayo, Weaver, Mary, Maneno, Earl, Ettienne, Julia Yunkyung, Yi, Laura, Hart, Shelly, Gray, Stephanie, Ozalas, Kayla, Miller, Rohini, Dave, Jacqueline, Bork, Janetta, Emmelhainz, Kaylee, Adams, Joshua, Postolski, Matthew, Willoughby, Elizabeth, Feldman, Kelly, Braham, Christopher, Miller, Deena, Barbagallo, Robert, Seabury, John, Noviasky, Jayvir, Dabhi, Donna, Bartlett, Tham, Le, Linda, Simoni-Wastila, Aida, Kuzucan, Siyeon, Park, Michelle, Choi, Bilal, Khokhar, Peter, Brody, Mary, Hejna, Jessica, Mason, Miranda, Graham, Jessica, Micceri, Roksolana, Lypska, Bryan, Quinn, Henry, Wilson, Robert, Wahler, Marissa, Aloyo, Vanessa, Tomm, Angela, Hill, Alan, Obringer, Kirsten, Butterfoss, Julia, Blak, Rebecca, Balcer, Jenna, Boza, Amanda, Foster, Ehtesham, Shafique, Casondra, Kleven, Patricia, Wigle, Bethanne, Brown, Kristin, Meyer, Wendy, Mobley-Bukstein, Hemlata, Singh, Emelia, Perez, Alaa-Eldin, Mira, William, Kuehner, Lou, Czechowski, Heather, Cook, Nicole, Brandt, Janee, Parson, Rachyl, Fornaro, Kimberly, Claeys, Barbara, Zarowitz, Daniel, Mansour, Chelsea, McFadden, Sierra, Simpkins, Folarin, Ojowa, Abigail, Klutts, Sarah, Holmes, Everett, Smith, Jr Reba, Cornman, Kelly, Doran, Barbara, Resnick, Chinasa, Umeozulu, Anne, Williams, George, Hennawi, Danielle, Thomas, Dawn Knudsen, Gerber, Kriti, Sharma, Catherine, Cooke, Amy, Howard, Rebecca, Chater, Abbie, Vogler, Kaitlyn, Kennett-Hayes, Laura, Elliott, John, Engelbert, Emily, Hargrave, Chynna, Bambico, Kripali, Patel, Cynthia, Warriner, Nihar R, Desai, Christopher G, Rowan, Paula, Alvarez, Jeanene, Fogli, Robert D, Toto, Pamala, Reed, Mary Kay, Owens, John F, Greden, Anthony J, Rothschild, Shannon, Zandy, Michael, Thase, Boadie W, Dunlop, Charles, DeBattista, Charles R, Conway, Brent P, Forester, Francis M, Mondimore, Richard C, Shelton, James, Li, Alexa, Gilbert, Lindsey, Burns, Michael, Jablonski, Bryan, Dechairo, Sagar, Parikh, James, Donohue, Gregory, Feldman, Sanjay, Sethi, Chris, Barnes, Srikanth, Pendyala, David, Bourdet, Gary, Ferguson, Glenn, Crater, Martha, Mayo, Coleman, Gross, John, Miyawa, Reyn, Ono, Steven, Woods, Dahlia, Garza, Natalie, Panov, Edmund, Moran, Vijay, Sabesan, James, Wertman, Kenley, Ngim
Publikováno v:
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 33(10)
Poster abstracts are evaluated based on the following criteria: significance of the problem to healthy aging or medication management; innovativeness of ideas, methods, and/or approach; methodological rigor of methods and approach; presentation of fi
Autor:
Bertram Pitt, Dahlia Garza
Publikováno v:
Expert opinion on drug safety. 17(5)
Hyperkalemia (HK) occurs often among patients with chronic kidney disease (CKD) and heart failure (HF) and those treated with renin-angiotensin-aldosterone system inhibitors (RAASI). Even small deviations from normal potassium levels carry increased
Autor:
Heidi Christ-Schmidt, David A. Bushinsky, Lance Berman, Yuri Stasiv, Bertram Pitt, Martha Mayo, Dahlia Garza, Matthew R. Weir, George L. Bakris
Publikováno v:
European Journal of Heart Failure. 17:1057-1065
Aims We evaluated the effects of patiromer, a potassium (K+)-binding polymer, in a pre-specified analysis of hyperkalaemic patients with heart failure (HF) in the OPAL-HK trial. Methods and results Chronic kidney disease (CKD) patients on renin–ang
Autor:
Bertram, Pitt, George L, Bakris, Matthew R, Weir, Mason W, Freeman, Mitja, Lainscak, Martha R, Mayo, Dahlia, Garza, Rezi, Zawadzki, Lance, Berman, David A, Bushinsky
Publikováno v:
ESC Heart Failure
Aims Chronic kidney disease (CKD) in heart failure (HF) increases the risk of hyperkalaemia (HK), limiting angiotensin‐converting enzyme inhibitor (ACE‐I) or angiotensin receptor blocker (ARB) use. Patiromer is a sodium‐free, non‐absorbed pot